Sponsored by:

Molecular Imaging: Page 272

IBA results improve in fiscal 2012
By AuntMinnie.com staff writers
Radiopharmaceutical provider Ion Beam Applications (IBA) benefited from increasing market adoption and expanded use of proton therapy treatment, increasing revenues for sales and services by 8.8% during its 2012 fiscal year compared with 2011.
March 18, 2013
SNMMI offers online dose information
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has launched a new online resource for imaging professionals, referring physicians, and the public on dose optimization for nuclear medicine and molecular imaging procedures.
March 18, 2013
NuView touts breast cancer imaging agent study
By AuntMinnie.com staff writers
Radiopharmaceutical developer NuView Life Sciences is touting a phase I feasibility study of its NLS-VPAC1 breast cancer imaging agent.
March 17, 2013
CMS to loosen strings on oncology PET payments
By Brian Casey
In a move that should make PET reimbursement easier for most oncology applications, the U.S. Centers for Medicare and Medicaid Services (CMS) this week proposed removing its longstanding requirement that FDG-PET scans of patients with solid tumors be reported to a national data registry.
March 13, 2013
PETNet grows Amyvid distribution network
By AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has expanded its U.S. manufacturing and distribution network for Eli Lilly's PET tracer Amyvid (florbetapir) to a total of 17 metropolitan areas.
March 13, 2013
FDA clears Navidea's Lymphoseek
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration announced it has cleared radiopharmaceutical developer Navidea Biopharmaceuticals' Lymphoseek diagnostic imaging agent.
March 12, 2013
Universal Medical to sell DDD gamma cameras
By AuntMinnie.com staff writers
Universal Medical Resources has signed on to handle U.S. distribution of the CorCam dedicated cardiac gamma camera from Danish nuclear medicine technology developer DDD-Diagnostic.
March 11, 2013
'Unfair' regulatory stance on radiotracers poses threat to PET's future
By Becky McCall
VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.
March 10, 2013
2013 03 11 14 43 21 277 2013 03 11 Von Schulthess 70
IBA Molecular starts Zr-89 production in U.S.
By AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular North America is now producing zirconium-89 (Zr-89) at its radiopharmaceutical plant in Richmond, VA.
March 10, 2013
PET/MR shows great potential for detecting multifocal cancers
By Becky McCall
VIENNA - PET/MRI allows superior early detection and evaluation of cancers as they disseminate around the body. That was the key message of Dr. Heinz-Peter Schlemmer in his talk in Saturday's new horizons session at ECR 2013.
March 9, 2013
2013 03 10 12 02 05 916 2013 03 10 Schlemmer Heinz Peter 175 20130310190602
CMS reconsiders oncology PET tracer coverage limitations
By Erik L. Ridley
As it had proposed in December, the U.S. Centers for Medicare and Medicaid Services (CMS) has removed a national noncoverage determination for radiopharmaceuticals with oncology PET imaging. However, CMS was not swayed by lobbying efforts to also include cardiac and neurological applications in the decision.
March 7, 2013
Ga-68 DOTATOC PET/MRI tops PET/CT for staging neuroendocrine tumors
By Wayne Forrest
VIENNA - Researchers from University Hospital Essen in Germany have shown the feasibility of whole-body staging of patients with neuroendocrine tumors with PET/MRI and the radiotracer gallium-68 (Ga-68) DOTATOC, and with greater reliability than PET/CT, in a preliminary study presented Friday at ECR 2013.
March 7, 2013
Previous Page
Page 272 of 612
Next Page